Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
09/2007
09/20/2007WO2007106705A1 Soluble epoxide hydrolase inhibitors and methods of using same
09/20/2007WO2007106467A2 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy) phenylacetyl]thiophene-3-sulfonamide, sodium salt
09/20/2007WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
09/20/2007WO2007105814A1 Substituted isoxazoline compound and pest control agent
09/20/2007WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
09/20/2007WO2007105753A1 Triazole derivative or salt thereof
09/20/2007WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007WO2007105650A1 4-hydroxyisoleucine derivative and process for producing the derivative
09/20/2007WO2007105053A2 Tetralines antagonists of the h-3 receptor
09/20/2007WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007WO2007104772A1 Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments
09/20/2007WO2007104695A1 Quinolin-4-ylhydrazine derivatives as antimalarial agent
09/20/2007WO2007104560A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
09/20/2007WO2007104538A1 Heterobicyclic carboxamides as inhibitors for kinases
09/20/2007WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
09/20/2007WO2007087518A3 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
09/20/2007WO2007084319A3 Diaryl piperidines as cb1 modulators
09/20/2007WO2007073698A8 2,2',6,6'-tetraoxazoline ligands with a biphenyl backbone and their preparation methods
09/20/2007WO2007071396A8 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
09/20/2007WO2005030712A3 Thrombin receptor antagonists
09/20/2007WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors
09/20/2007WO2002000649A9 Substituted quinazoline derivatives and their use as inhibitors
09/20/2007US20070219235 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
09/20/2007US20070219206 5-lipoxygenase-activating protein (flap) inhibitors
09/20/2007US20070219198 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) for treatment of Type 2 diabetes, syndrome X, dyslipidemias, atherosclerosis, Alzheimer's and as wound healing agents; (2R)-1,1,1-trifluoro-2-[3-({(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl}sulfonyl)phenyl]propan-2-ol for example
09/20/2007US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
09/20/2007US20070219196 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
09/20/2007US20070219193 Alkylamine-substituted bicyclic aryl compounds useful as modulators of ppar
09/20/2007US20070219189 Mif-inhibitors
09/20/2007US20070219188 Oxadiazine Derivatives
09/20/2007US20070219187 Allosteric Modulators of Metabotropic Glutamate Receptors
09/20/2007US20070219179 Indole Derivative Having Piperidine Ring
09/20/2007US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors
09/20/2007US20070215866 used in molecular scaled opto-electronic devices including field-effect transistors, light-emitting diodes and photovoltaic cells
09/20/2007US20070215844 Chromene Compound
09/20/2007CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007CA2646223A1 Novel heterocyclic nf-kb inhibitors
09/20/2007CA2645712A1 Triazole derivative or salt thereof
09/20/2007CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007CA2644134A1 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy)phenylacetyl]thiophene-3-sulfonamide, sodium salt
09/20/2007CA2644033A1 Heterobicyclic carboxamides as inhibitors for kinases
09/20/2007CA2643859A1 Soluble epoxide hydrolase inhibitors and methods of using same
09/20/2007CA2643222A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
09/20/2007CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
09/20/2007CA2643055A1 Tetralines antagonists of the h-3 receptor
09/20/2007CA2643026A1 Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments
09/19/2007EP1834953A1 Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
09/19/2007EP1833825A1 Tricyclic delta-opioid modulators
09/19/2007EP1833824A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands
09/19/2007EP1833823A1 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
09/19/2007EP1833816A1 Substituted piperidines as renin inhibitors
09/19/2007EP1833806A1 Oxadiazole derivatives as dgat inhibitors
09/19/2007EP1833805A1 New 3-phenylpropionic acid derivatives for the treatment of diabetes
09/19/2007EP1833802A2 1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
09/19/2007EP1833797A1 Azacyclic compounds as inhbitors of sensory neurone specific channels (sns)
09/19/2007EP1833795A1 Pyridine compounds for the treatment of prostaglandin mediated diseases
09/19/2007EP1833792A1 Substituted piperidine compounds for use as ccr5 modulators
09/19/2007EP1664025B1 Pyrrol derivatives with antibacterial activity
09/19/2007EP1585734A4 Anti-inflammatory medicaments
09/19/2007CN101039938A Diphenyl substituted alkanes as flap inhibitors
09/19/2007CN101039937A Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
09/19/2007CN101039936A Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
09/19/2007CN101039933A Diaminotriazole compounds useful as protein kinase inhibitors
09/19/2007CN101039932A Heterocyclic substituted bisarylurea derivatives as kinase inhibitors
09/19/2007CN101039929A Novel anthranilamides useful for controlling invertebrate pests
09/19/2007CN101039920A 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
09/19/2007CN101039919A N-benzenesulfonyl substituted anilino-pyrimidine analogs
09/19/2007CN101039904A Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
09/19/2007CN101039662A Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
09/19/2007CN101037435A (S)-nifuratel, preparation method and application thereof
09/19/2007CN101037434A Production method of nifuratel
09/19/2007CN100338073C Substituted phenylacetic acids
09/19/2007CN100338057C Halogenated nitrobutadienes for controlling animal pests
09/19/2007CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
09/19/2007CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors
09/19/2007CN100338036C Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes
09/18/2007US7271406 Electron transport agents for organic electronic devices
09/18/2007US7271268 Reacting methyl [1-(mercaptomethyl)cyclopropyl]acetate with with a base in a solvent of an alcohol
09/18/2007US7271252 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay
09/18/2007US7271192 Nitrogen oxide synthase inhibitors; synthesis
09/18/2007US7271190 Indazole compounds as β3 adrenoceptor agonist
09/18/2007US7271168 Piperazine derivatives having SST1 antagonistic activity
09/18/2007US7271154 Such as penicillin G coupled to 2'deoxyazithromycin; drug delivery
09/18/2007CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
09/18/2007CA2177143C Metal chelate containing compositions for use in chemiluminescent assays
09/18/2007CA2095797C Arylacetamides
09/13/2007WO2007103554A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
09/13/2007WO2007103260A1 Phosphodiesterase 10 inhibitors
09/13/2007WO2007102769A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
09/13/2007WO2007102059A1 Sulfonyl benzimidazole derivatives
09/13/2007WO2007101573A1 Substituted arylsulfonamides as antiviral agents
09/13/2007WO2007101347A1 Bir domain binding compounds
09/13/2007WO2007087488A3 Indole sulfonamide modulators of progesterone receptors
09/13/2007WO2007060140A3 Inhibitors of diacyglycerol acyltransferase (dgat)
09/13/2007WO2007039178A3 Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
09/13/2007WO2007030559A3 1, 3-disubstituted indole derivatives for use as ppar modulators
09/13/2007WO2007027238A3 Jak kinase inhibitors and their uses
09/13/2007US20070213374 Malonamide Derivatives
09/13/2007US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
09/13/2007US20070213346 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists